Drug Pipeline

Fluoropyrimidine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06648785 Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies GI Cancers Enrolling by Invitation
Phase 1
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients… Autoimmune Disease Recruiting
Not specified
NCT07494578 Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in… Colon Cancer Metastatic Active, Not Recruiting
Sponsors Running Fluoropyrimidine Trials
National Cancer Institute (NCI) (1) University of Vermont Medical Center (1) Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)
Disease Areas
Multiple Sclerosis (1) Rheumatoid Arthritis (1) Lupus (SLE) (1) Crohn's Disease (1) Ulcerative Colitis (1) Psoriasis (1) Psoriatic Arthritis (1) Scleroderma (1) Colorectal Cancer (1)
Get alerts when Fluoropyrimidine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free